What did @thedebway actually say?
Straightforwardly: not much about Mounjaro at all. The transcript is a string of song lyrics, specifically lines from Kanye West's "Homecoming" or a similar track, ending mid-sentence with "I'ma test." The only health-adjacent signal here is the caption: "Best thing I ever did" paired with Mounjaro hashtags. That caption is the real claim being made, and it's worth treating seriously even if the video itself is just vibes and background music.
The creator isn't explaining a mechanism, citing a dose, or making a specific medical argument. They're sharing a feeling. That's common in the GLP-1 content space, where personal testimony and emotional framing often carry more weight with viewers than anything a clinician would say. That doesn't make it harmless, but it does change how we should read it.
Does the science back up the implied claim?
The implied claim, that Mounjaro (tirzepatide) is life-changing for weight loss or diabetes management, is actually fairly well-supported in the clinical literature. So credit where it's due.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that tirzepatide at 15mg produced a mean body weight reduction of 20.9% over 72 weeks in adults with obesity but without diabetes. That's a larger effect than anything previously seen in a licensed weight-loss drug. The SURPASS trial series showed similar results in type 2 diabetes populations, with meaningful HbA1c reductions alongside weight loss.
If someone who has struggled with their weight for years starts tirzepatide and says "this is the best thing I ever did," that reaction is consistent with what trial participants reported. Patient-reported quality of life scores in SURMOUNT-1 improved significantly alongside the weight outcomes. So the emotional framing here, while anecdotal, is not wildly out of step with what the data shows.
What did they get wrong, or right?
They didn't get anything technically wrong because they didn't technically say anything clinical. But the format itself carries risks worth naming.
Testimonial-style content about prescription medications, even when it's just a caption and some hashtags, functions as implicit advertising. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has been increasingly clear that social media promotion of prescription-only medicines by patients and influencers sits in a legal grey zone that regulators are watching closely. In the UK, Mounjaro (tirzepatide) is licensed for both type 2 diabetes and weight management, but it is still a prescription-only medicine.
The bigger risk isn't what this creator said. It's what viewers might do next: assume they can get it easily, that it works the same for everyone, or that the "best thing I ever did" framing applies universally. Tirzepatide has a real side effect profile including nausea, vomiting, gastroparesis risk, and potential pancreatitis concerns flagged in post-marketing surveillance.
What should you actually know?
If you're considering Mounjaro, the evidence base is genuinely strong, but that's not the same as saying it's right for you without medical assessment.
- Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is mechanistically distinct from semaglutide (Ozempic, Wegovy). The dual agonism appears to drive larger weight loss, but it also means the side effect and contraindication profile is not identical.
- In the UK, accessing Mounjaro for weight management requires a BMI of 35 or higher (or 30 with weight-related comorbidities) through NHS pathways, or via regulated private providers who must conduct proper clinical assessment.
- The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) showed significant weight regain after stopping tirzepatide, which is important context the "best thing I ever did" framing tends to leave out entirely.
- Compounded versions of tirzepatide are not equivalent to licensed Mounjaro. Regulatory bodies in both the UK and US have issued warnings about compounded GLP-1 products.
Enthusiasm for a drug that genuinely works is understandable. But enthusiasm without context is how people end up on medications they're not suited for, or sourced from places they shouldn't be sourcing from.